Physiomics PLC Advisor Changes (0022L)
September 28 2016 - 1:00AM
UK Regulatory
TIDMPYC
RNS Number : 0022L
Physiomics PLC
28 September 2016
Physiomics plc
("Physiomics") or ("the Company")
Advisor Changes
Physiomics plc (AIM: PYC), the Oxford, UK based systems biology
company, is pleased to announce the appointment of Hybridan LLP as
sole broker with effect from 28(th) December 2016 until which time
WH Ireland will continue to act as co-broker alongside Hybridan. WH
Ireland will remain the Company's NOMAD.
Enquiries:
Physiomics plc
Dr Jim Millen, CEO
+44 (0)1865 784 980
WH Ireland Limited (nomad and joint broker)
Katy Mitchell
+44 (0) 161 832 2174
Hybridan LLP (joint broker)
Claire Louise Noyce
+44 (0) 203 764 2341
About Physiomics plc
Physiomics (AIM:PYC) is a computational systems biology services
company applying simulations of cell behaviour to drug development
to reduce the high attrition rates of clinical trials. 80-90 per
cent of all clinical drug candidates fail to reach the market and
estimates show that an overall ten per cent improvement in success
rates could reduce the cost of one drug's development by as much as
$242 million, from the current estimate of around $800 million(1)
.
Physiomics develops computational systems biology models to
predict and understand cancer drug efficacy from pre-clinical
research to clinical development. Physiomics has created detailed
mathematical models incorporating the most important molecular
events taking place during the human cell cycle and apoptosis
processes. The company's SystemCell(R) technology enables the
simulation of populations of "virtual cells". The company has also
developed a "Virtual Tumour" model to simulate the effect of
anti-cancer drugs on tumour growth. The models are used to optimise
compound design and to design drug schedules and combination
therapies.
Physiomics, based in Oxford, UK, was founded in 2001, and
floated on AIM in 2004. For further information, please visit
www.physiomics-plc.com
SystemCell(R) is a registered trademark of Physiomics plc
(1) Tufts Centre Impact Report 2002
This information is provided by RNS
The company news service from the London Stock Exchange
END
MSCEAKNXALEKEFF
(END) Dow Jones Newswires
September 28, 2016 02:00 ET (06:00 GMT)
Physiomics (LSE:PYC)
Historical Stock Chart
From Apr 2024 to May 2024
Physiomics (LSE:PYC)
Historical Stock Chart
From May 2023 to May 2024